Searches , social queries for ERBB4

Search references for ERBB4. Phrases containing ERBB4

See searches and references containing ERBB4!

Searches containing ERBB4

ERBB4

  • ERBB4
  • Protein-coding gene in the species Homo sapiens

    tyrosine-protein kinase erbB-4 is an enzyme that in humans is encoded by the ERBB4 gene. Alternatively spliced variants that encode different protein isoforms

    ERBB4

    ERBB4

    ERBB4

  • Neuregulin 1
  • Protein-coding gene in the species Homo sapiens

    some types (I and IV) can be regulated by neuronal activity. Neuregulin 1-ErbB4 interactions are thought to play a role in the pathological mechanism of

    Neuregulin 1

    Neuregulin 1

    Neuregulin_1

  • Neuregulin 3
  • Protein-coding gene in Homo sapiens

    available about the other genes of the family. NRGs bind to the ERBB3 and ERBB4 tyrosine kinase receptors; they then form homodimers or heterodimers, often

    Neuregulin 3

    Neuregulin 3

    Neuregulin_3

  • Soluble fms-like tyrosine kinase-1
  • Protein with antiangiogenic properties

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    Soluble fms-like tyrosine kinase-1

    Soluble_fms-like_tyrosine_kinase-1

  • Aurintricarboxylic acid
  • Chemical compound

    phosphorylation processes including the Jak2/STAT5 pathway in NB2 lymphoma cells, ErbB4 in neuroblastoma cells, and MAP kinases, Shc proteins, phosphatidylinositide

    Aurintricarboxylic acid

    Aurintricarboxylic acid

    Aurintricarboxylic_acid

  • Testosterone
  • Primary male sex hormone

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Testosterone

    Testosterone

    Testosterone

  • Amitriptyline
  • Tricyclic antidepressant

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Eutropoflavin
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Eutropoflavin

    Eutropoflavin

    Eutropoflavin

  • Trametinib
  • Anticancer medication

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Trametinib

    Trametinib

    Trametinib

  • Cetuximab
  • Pharmaceutical drug

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Cetuximab

    Cetuximab

    Cetuximab

  • ErbB
  • Family of proteins

    family includes Her1 (EGFR, ErbB1), Her2 (ErbB2), Her3 (ErbB3), and Her4 (ErbB4). The gene symbol, ErbB, is derived from the name of a viral oncogene to

    ErbB

    ErbB

  • Filgrastim
  • Medication

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Filgrastim

    Filgrastim

    Filgrastim

  • Avapritinib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Avapritinib

    Avapritinib

    Avapritinib

  • Acalabrutinib
  • Chemical compound

    otherwise virtually no inhibition on the kinase activities of ITK, EGFR, ERBB2, ERBB4, JAK3, BLK, FGR, FYN, HCK, LCK, LYN, SRC, and YES1. In addition, in platelets

    Acalabrutinib

    Acalabrutinib

    Acalabrutinib

  • Afatinib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Afatinib

    Afatinib

    Afatinib

  • Trastuzumab
  • Medication

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • FGF16
  • Protein-coding gene in the species Homo sapiens

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    FGF16

    FGF16

    FGF16

  • Erythropoietin
  • Protein that stimulates red blood cell production

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Antineoplastic
  • Class of drugs used to treat malignant tumors

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Cyclotraxin B
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Cyclotraxin B

    Cyclotraxin B

    Cyclotraxin_B

  • Ciliary neurotrophic factor receptor
  • Protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Ciliary neurotrophic factor receptor

    Ciliary neurotrophic factor receptor

    Ciliary_neurotrophic_factor_receptor

  • Robatumumab
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Robatumumab

    Robatumumab

  • Brain-derived neurotrophic factor
  • Protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • Neurotrophic factors
  • Family of biomolecules

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Neurotrophic factors

    Neurotrophic_factors

  • Insulin-like growth factor 2 receptor
  • Protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Insulin-like growth factor 2 receptor

    Insulin-like growth factor 2 receptor

    Insulin-like_growth_factor_2_receptor

  • Isoform
  • Different products from the same gene

    (December 2010). "Cell death or survival promoted by alternative isoforms of ErbB4". Molecular Biology of the Cell. 21 (23): 4275–86. doi:10.1091/mbc.E10-04-0332

    Isoform

    Isoform

    Isoform

  • Epiregulin
  • Protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Epiregulin

    Epiregulin

    Epiregulin

  • Nerve growth factor
  • Mammalian protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Nerve growth factor

    Nerve growth factor

    Nerve_growth_factor

  • Epidermal growth factor receptor
  • Transmembrane protein

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • HER2
  • Mammalian protein found in humans

    (May 2000). "Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses". Neuron. 26 (2): 443–455. doi:10.1016/s0896-6273(00)81176-9

    HER2

    HER2

    HER2

  • Tavilermide
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Tavilermide

    Tavilermide

    Tavilermide

  • Insulin
  • Peptide hormone

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Insulin

    Insulin

    Insulin

  • Amivantamab
  • Monoclonal antibody

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Amivantamab

    Amivantamab

    Amivantamab

  • CSPG5
  • Protein-coding gene in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    CSPG5

    CSPG5

    CSPG5

  • Ranibizumab
  • Pharmaceutical drug

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Ranibizumab

    Ranibizumab

  • Dexamethasone
  • Corticosteroid medication

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Dexamethasone

    Dexamethasone

    Dexamethasone

  • Fibroblast growth factor receptor 2
  • Protein-coding gene in the species Homo sapiens

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    Fibroblast growth factor receptor 2

    Fibroblast growth factor receptor 2

    Fibroblast_growth_factor_receptor_2

  • Insulin-like growth factor 1
  • Protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Insulin-like growth factor 1

    Insulin-like growth factor 1

    Insulin-like_growth_factor_1

  • Hepatocyte growth factor
  • Mammalian protein found in Homo sapiens

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Hepatocyte growth factor

    Hepatocyte growth factor

    Hepatocyte_growth_factor

  • Estradiol valerate/prasterone enanthate
  • Combination drug

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Estradiol valerate/prasterone enanthate

    Estradiol valerate/prasterone enanthate

    Estradiol_valerate/prasterone_enanthate

  • Neuregulin 4
  • Protein-coding gene in the species Homo sapiens

    neuregulins, including NRG4, activate erb-b2 receptor tyrosine kinase 4 (ERBB4) to initiating cell signaling through cytosolic tyrosine phosphorylation

    Neuregulin 4

    Neuregulin 4

    Neuregulin_4

  • Imatinib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Imatinib

    Imatinib

    Imatinib

  • Dihexa
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Dihexa

    Dihexa

    Dihexa

  • DDR1
  • Protein-coding gene in the species Homo sapiens

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    DDR1

    DDR1

    DDR1

  • DLG4
  • Mammalian protein found in Homo sapiens

    Beta-1 adrenergic receptor CACNG2 CASK DLG3 DLGAP1 DLGAP2 DYNLL1 DYNLL2 ERBB4 EXOC4 FYN FZD7 GRIK1 GRIK2 GRIK5 GRIN2A GRIN2B GRIN2C HER2/neu HGS KCNA2

    DLG4

    DLG4

    DLG4

  • Fosgonimeton
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Fosgonimeton

    Fosgonimeton

    Fosgonimeton

  • Dehydroepiandrosterone sulfate
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone_sulfate

  • Braegen-02
  • Pharmaceutical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Braegen-02

    Braegen-02

    Braegen-02

  • TNK2
  • Protein-coding gene in the species Homo sapiens

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    TNK2

    TNK2

    TNK2

  • Cerebrolysin
  • Experimental drug for neurodegenerative disorders

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Cerebrolysin

    Cerebrolysin

  • Gamma secretase
  • Type of protein

    processing of several other type I integral membrane proteins, such as Notch, ErbB4, E-cadherin, N-cadherin, ephrin-B2, or CD44. The gamma secretase complex

    Gamma secretase

    Gamma secretase

    Gamma_secretase

  • Rociletinib
  • Cancelled developmental cancer drug

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Rociletinib

    Rociletinib

    Rociletinib

  • Trastuzumab deruxtecan
  • Medication

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Vascular endothelial growth factor
  • Protein involved in blood vessel growth

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Vascular endothelial growth factor

    Vascular_endothelial_growth_factor

  • HCK
  • Protein-coding gene in humans

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    HCK

    HCK

    HCK

  • Vemurafenib
  • Targeted cancer drug

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Vemurafenib

    Vemurafenib

    Vemurafenib

  • Lorlatinib
  • Kinase inhibitor for treatment of non-small-cell lung cancer

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Lorlatinib

    Lorlatinib

    Lorlatinib

  • Ephrin receptor
  • Protein family

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    Ephrin receptor

    Ephrin receptor

    Ephrin_receptor

  • Transforming growth factor
  • Biomarker indicative of breast cancer patients' prognosis

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Transforming growth factor

    Transforming_growth_factor

  • Asciminib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Asciminib

    Asciminib

    Asciminib

  • Figitumumab
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Figitumumab

    Figitumumab

  • ROR1
  • Protein-coding gene in the species Homo sapiens

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    ROR1

    ROR1

    ROR1

  • Insulin-like growth factor
  • Proteins similar to insulin that stimulate cell proliferation

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Insulin-like growth factor

    Insulin-like growth factor

    Insulin-like_growth_factor

  • Anti-VEGF
  • Medication which blocks growth of blood vessels

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • Norwogonin
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Norwogonin

    Norwogonin

    Norwogonin

  • Binimetinib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Binimetinib

    Binimetinib

    Binimetinib

  • ProtCID
  • Leahy, D. J. (2008). "Mechanism of Activation and Inhibition of the HER4/ErbB4 Kinase". Structure. 16 (3): 460–467. doi:10.1016/j.str.2007.12.016. PMC 2858219

    ProtCID

    ProtCID

    ProtCID

  • Diosmetin
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Diosmetin

    Diosmetin

    Diosmetin

  • Vascular endothelial growth factor B
  • Protein-coding gene in the species Homo sapiens

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Vascular endothelial growth factor B

    Vascular endothelial growth factor B

    Vascular_endothelial_growth_factor_B

  • Receptor tyrosine kinase
  • Class of enzymes

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Fibroblast growth factor 23
  • Protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Fibroblast growth factor 23

    Fibroblast growth factor 23

    Fibroblast_growth_factor_23

  • Panitumumab
  • Pharmaceutical drug

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Panitumumab

    Panitumumab

  • Megakaryocyte-associated tyrosine kinase
  • Protein-coding gene in the species Homo sapiens

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    Megakaryocyte-associated tyrosine kinase

    Megakaryocyte-associated tyrosine kinase

    Megakaryocyte-associated_tyrosine_kinase

  • Wnt signaling pathway
  • Group of signal transduction pathways involved in embryonic development

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Wnt signaling pathway

    Wnt_signaling_pathway

  • NMDA receptor
  • Glutamate receptor and ion channel protein found in nerve cells

    process that is independent of neuregulin beta signaling through ErbB2 and ErbB4 receptors. NMDA receptors have been implicated by a number of studies to

    NMDA receptor

    NMDA receptor

    NMDA_receptor

  • MST1
  • Protein-coding gene in the species Homo sapiens

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    MST1

    MST1

    MST1

  • Tovetumab
  • Monoclonal antibody

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Tovetumab

    Tovetumab

  • Tyrosine kinase inhibitor
  • Drug typically used in cancer treatment

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Placental growth factor
  • Protein-coding gene in the species Homo sapiens

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Placental growth factor

    Placental growth factor

    Placental_growth_factor

  • Greg Lemke
  • American neuroscientist, immunologist, and author

    he, along with his colleagues used loss-of-function mutants to show that ErbB4, a receptor for GGF and related ‘neuregulins’, is essential for cardiac

    Greg Lemke

    Greg Lemke

    Greg_Lemke

  • Pazopanib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Pazopanib

    Pazopanib

  • Selpercatinib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Selpercatinib

    Selpercatinib

    Selpercatinib

  • Dasatinib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Dasatinib

    Dasatinib

    Dasatinib

  • Growth factor
  • Protein or other substance that stimulates cellular proliferation

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Growth factor

    Growth_factor

  • Brigatinib
  • ALK inhibitor for treatment of non-small-cell lung cancer

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Brigatinib

    Brigatinib

    Brigatinib

  • Genetics of amyotrophic lateral sclerosis
  • Association between genetics and ALS

    Fujiyama A, Morishita S, Goto J, Tsuji S (2013). "ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19"

    Genetics of amyotrophic lateral sclerosis

    Genetics_of_amyotrophic_lateral_sclerosis

  • Neuregulin
  • Family of four EGF proteins

    erbB family of receptor tyrosine kinases (erbB2 (HER2), erbB3 (HER3), and erbB4 (HER4)), functioning both as heterodimers and homodimers. The neuregulin

    Neuregulin

    Neuregulin

    Neuregulin

  • Fibroblast growth factor 21
  • Protein-coding gene in mammals

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Fibroblast growth factor 21

    Fibroblast growth factor 21

    Fibroblast_growth_factor_21

  • Fibroblast growth factor receptor-like 1
  • Protein found in humans

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Fibroblast growth factor receptor-like 1

    Fibroblast growth factor receptor-like 1

    Fibroblast_growth_factor_receptor-like_1

  • Infigratinib
  • Medication

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Infigratinib

    Infigratinib

  • Pegfilgrastim
  • Monoclonal antibody

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Pegfilgrastim

    Pegfilgrastim

  • GFRA4
  • Protein-coding gene in the species Homo sapiens

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    GFRA4

    GFRA4

    GFRA4

  • Tyrosine kinase
  • Enzyme

    EPHA7; EPHA8; EPHA10; EPHB1; EPHB2; EPHB3; EPHB4; EPHB6; ERBB2; ERBB3; ERBB4; FER; FES; FGFR1; FGFR2; FGFR3; FGFR4; FGR; FLT1; FLT3; FLT4; FRK; FYN;

    Tyrosine kinase

    Tyrosine kinase

    Tyrosine_kinase

  • Jessica Cardin
  • American neuroscientist

    neural circuit regulation. By removing a critical signalling receptor, ErbB4, from VIP neurons, Cardin and her team saw deficits in sensory processing

    Jessica Cardin

    Jessica_Cardin

  • Fasinumab
  • Monoclonal antibody

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Fasinumab

    Fasinumab

  • Nilotinib
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Nilotinib

    Nilotinib

    Nilotinib

  • Colony stimulating factor 1 receptor
  • Protein found in humans

    2.7.10.1) Growth factor receptors EGF receptor family EGFR ERBB2 ERBB3 ERBB4 Insulin receptor family IGF1R INSR INSRR PDGF receptor family CSF1R FLT3

    Colony stimulating factor 1 receptor

    Colony stimulating factor 1 receptor

    Colony_stimulating_factor_1_receptor

  • Evinacumab
  • Monoclonal antibody

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Evinacumab

    Evinacumab

  • Prasterone enanthate
  • Chemical compound

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Prasterone enanthate

    Prasterone enanthate

    Prasterone_enanthate

  • Stem cell factor
  • Mammalian protein found in Homo sapiens

    2, 6 (neuroglycan C)) Antibodies: Duligotuzumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding EGF-like growth factor

    Stem cell factor

    Stem cell factor

    Stem_cell_factor

Searches for online references containing ERBB4

ERBB4

Search references containing ERBB4

ERBB4

Search queries for Facebook and twitter posts, hashtags with ERBB4

ERBB4

Follow users with usernames @ERBB4 or posting hashtags containing #ERBB4

ERBB4

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with ERBB4

ERBB4

Top search, Social media, medium, facebook & news articles containing ERBB4

ERBB4

Searches for Acronyms & meanings containing ERBB4

ERBB4

Searches, Indeed job searches and job offers containing ERBB4

Other words and meanings similar to

ERBB4

Search in online dictionary sources & meanings containing ERBB4

ERBB4